Isarna Therapeutics is and was supported by an international team of scientists, researchers, and clinicians who are leading experts in the fields of TGF-β, translational medicine and ophthalmology.
Frank Holz, MD
Chairman and Professor, Department of Ophthalmology, University of Bonn, Germany
Philip J Rosenfeld, MD, Ph.D
Professor, Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, USA
Marco Zarbin, MD
Rosemary Akhurst, Ph.D.
Professor and Director of Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA
Alon Harris, Ph.D., FARVO
Professor of Ophthalmology, Director of Clinical Research, Professor of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, USA
Ugur Sahin, M.D.
Professor of Experimental Oncology, Founder and Managing Director (Science and Research) of TRON GmbH, Mainz, Germany
David Spalton, M.D.
Professor of Ophthalmology, The London Clinic Eye Centre, London, United Kingdom
Walter Stark, M.D.
Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of the Wilmer Eye Institute at the Johns Hopkins Medical Institutions, Johns Hopkins University, Baltimore, USA
Josep Tabernero, M.D.
Professor and Director of Vall d'Hebron Institute of Oncology, Head Medical Oncology Department, Director Clinical Research, Barcelona, Spain
Rohit Varma, M.D.
Professor and Chair of the Department of Ophthalmology at the University of Southern California and Director USC Eye Institute, Keck School of Medicine of USC, Los Angeles, USA
Michael Weller, M.D.
Professor of Neurology, Chairman of the Department of Neurology, University Hospital Zurich, Switzerland
Michael Wormstone, Ph.D.
Faculty Member and Senior Lecturer at the School of Biological Sciences, University of East Anglia, Norwich, United Kingdom